Cover Image
市場調查報告書

肛門失禁 (大便失禁):全球臨床實驗趨勢

Anal Incontinence Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 330942
出版日期 內容資訊 英文 49 Pages
訂單完成後即時交付
價格
Back to Top
肛門失禁 (大便失禁):全球臨床實驗趨勢 Anal Incontinence Global Clinical Trials Review, H1, 2015
出版日期: 2015年04月28日 內容資訊: 英文 49 Pages
簡介

本報告提供肛門失禁 (大便失禁) 相關臨床研究之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,受驗者採用狀況,有潛力的贊助商,各企業和研究機關上研究的進展,有潛力的藥劑比較等資訊。

簡介

  • 肛門失禁
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 歐洲的主要5國臨床實驗數量
    • 北美的主要國家臨床實驗數量
    • 中東·非洲的主要國家臨床實驗數量
    • 中南美的主要國家臨床實驗數量

G7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上肛門失禁的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標的達成情形

未完成的臨床實驗數量

一定期間所採用的受驗者

贊助商類別的臨床實驗數量

有潛力的贊助商

肛門失禁治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • S.L.A. Pharma AG
    • RDD Pharma Ltd.
    • Laboratoire HRA Pharma
  • 有代表性的研究機關·醫院臨床實驗概要
    • Centre Hospitalier Universitaire - Hopitaux de Rouen
    • Bezirkskrankenhaus Schwaz
    • Dalhousie University
    • Herlev Hospital
    • Pontificia Universidad Catolica de Chile
    • Uppsala University Hospital

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2653CTIDB

GlobalData's clinical trial report, "Anal Incontinence Global Clinical Trials Review, H1, 2015" provides data on the Anal Incontinence clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anal Incontinence. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anal Incontinence. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Anal Incontinence
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Anal Incontinence to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Anal Incontinence
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Anal Incontinence Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • S.L.A. Pharma AG
      • Clinical Trial Overview of S.L.A. Pharma AG
      • RDD Pharma Ltd.
      • Clinical Trial Overview of RDD Pharma Ltd.
      • Laboratoire HRA Pharma
      • Clinical Trial Overview of Laboratoire HRA Pharma
    • Clinical Trial Overview of Top Institutes / Government
      • Centre Hospitalier Universitaire - Hopitaux de Rouen
      • Clinical Trial Overview of Centre Hospitalier Universitaire - Hopitaux de Rouen
      • Bezirkskrankenhaus Schwaz
      • Clinical Trial Overview of Bezirkskrankenhaus Schwaz
      • Dalhousie University
      • Clinical Trial Overview of Dalhousie University
      • Herlev Hospital
      • Clinical Trial Overview of Herlev Hospital
      • Pontificia Universidad Catolica de Chile
      • Clinical Trial Overview of Pontificia Universidad Catolica de Chile
      • Uppsala University Hospital
      • Clinical Trial Overview of Uppsala University Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Anal Incontinence Therapeutics, Global, Clinical Trials by Region, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Anal Incontinence to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Anal Incontinence Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Anal Incontinence Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by S.L.A. Pharma AG, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by RDD Pharma Ltd., 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoire HRA Pharma, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire - Hopitaux de Rouen, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Bezirkskrankenhaus Schwaz, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Dalhousie University, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Pontificia Universidad Catolica de Chile, 2015*
  • Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Uppsala University Hospital, 2015*

List of Figures

  • Anal Incontinence Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Anal Incontinence Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Anal Incontinence to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Anal Incontinence Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Anal Incontinence Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Anal Incontinence Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top